Case series on aripiprazole and dopamine supersensitivity psychosis. (7th February 2022)

• Record Type: Journal Article
• Authors: Russell, Geoffrey; Reinfeld, Samuel; Kam, Olivia; Lee, Gloria; Weiss, Melissa; Mathew Koola, Maju
• Is Part Of: International clinical psychopharmacology. Volume 37:Number 3(2022)
• Page Start: 122
• Page End: 128
• Publication Date: 2022-02-07
• Subjects: aripiprazole -- dopamine supersensitivity psychosis -- switching to aripiprazole; Psychopharmacology -- Periodicals; Psychotropic drugs -- Periodicals; Psychopharmacology -- periodicals; Psychotropic Drugs -- periodicals; 615.7805
• DOI: 10.1097/YIC.0000000000000391
• Languages: English
• ISSNs: 0268-1315

Abstract

Abstract : A potential link between switching to aripiprazole and worsening of psychosis was first reported in the early 2000s. There have since been numerous published case reports describing this phenomenon, but only recently has the concept of a theoretical aripiprazole-induced dopamine supersensitivity psychosis (DSP) caused by D2 receptor activation in patients undergoing a switch to aripiprazole appeared in the literature. There is less awareness in clinical practice of the possibility of inducing DSP with aripiprazole, which may be particularly severe in some patients. The objective of this article is to present four cases demonstrating rapid and dramatic onset of DSP during switching to aripiprazole. In each case, a patient with a Diagnostic and statistical manual of mental disorders (5 th ed.) diagnosis of schizophrenia experienced severe worsening of psychosis within 4–5 days of abrupt switching to aripiprazole from a full D2 antagonist. To our knowledge, this is the first case series characterizing the previously well-documented worsening of psychosis during switching to aripiprazole specifically as aripiprazole-induced DSP. We discuss clinical relevance, prevention and future directions. Careful cross-titration per clinical practice guidelines may reduce occurrence of DSP during aripiprazole switching or augmentation treatment.